Singapore Health Sciences Authority Approves Biktarvy(R) (Bictegravir, Emtricitabine, Tenofovir Alafenamide) for Treatment of HIV-1 Infection
In Clinical Trials, Biktarvy Demonstrated High Efficacy and Zero Resistance Through 48 Weeks SINGAPORE, Feb. 14, 2019 /PRNewswire/ — Gilead Sciences, Inc. today announced that the Singapore Health Sciences Authority…
SK Biopharmaceuticals and Arvelle Therapeutics Announce Agreement to Develop and Commercialize Cenobamate in Europe
Arvelle Therapeutics to receive rights to develop and commercialize cenobamate, an investigational antiepileptic drug developed by SK Biopharmaceuticals, in Europe SK Biopharmaceuticals to receive upfront payment of $100 million and…
Novartis leverages digital transformation to address most pressing health challenges in Asia
SINGAPORE, Feb. 13, 2019 /PRNewswire/ — Novartis is on a mission to transform healthcare in Asia by partnering with the health tech ecosystem. Alexis Serlin, Head of Asia Cluster, Novartis…
GC Pharma Reports Full Year 2018 Results
Delivers Continued Momentum in 2018 Through Broadly-based Sales Growth YONGIN, South Korea, Feb. 12, 2019 /PRNewswire/ — GC Pharma (formerly known as Green Cross Corporation) (KRX: 006280), a South Korean…
Bridge Biotherapeutics Presented Preclinical and Phase I Study Results for BBT-401 at the Crohn’s & Colitis Congress
SEONGNAM, South Korea, Feb. 11, 2019 /PRNewswire/ — Bridge Biotherapeutics Inc., a clinical stage biotech company headquartered in Seongnam, South Korea, announced that the company presented the preclinical and the…
3SBio and Verseau Establish Global Clinical Development Collaboration for First-in-class Immuno-Oncology Therapies
SHENYANG, China and BOSTON, Feb. 11, 2019 /PRNewswire/ — 3SBio Inc. (“3SBio”) (HKEX:1530) and Verseau Therapeutics, Inc. (“Verseau”) announced today a partnership agreement focused on the development and commercialization of…
Let’s #Move8, Warriors!
#Move8 fitness movement is set to get 2 million Malaysians off their feet and move it! It is with great honour that we invite you aboard as a Move8 Warrior…
CStone and IMPACT Therapeutics’ clinical collaboration progresses to IND filing acceptance for CS1001+IMP4297 combination therapy
SUZHOU, China, Feb. 8, 2019 /PRNewswire/ — CStone Pharmaceutical (“CStone”) and IMPACT Therapeutics, Inc. (“IMPACT”) today jointly announced that an Investigational New Drug (IND) filing has been accepted by the…
Frost & Sullivan Releases 10 Growth Opportunities in Precision Medical Imaging
Medical imaging’s critical role in supporting high impact patient care approaches centred on outcomes SANTA CLARA, California, Feb. 7, 2019 /PRNewswire/ — The triple aim objectives in healthcare provision and…
Thailand Board of Investment Helps Promote Medical Robotics
BANGKOK, Thailand, Feb. 7, 2019 /PRNewswire/ — Under its Thailand 4.0 vision, Thailand plans to leverage on its reputation and excellence in medical services and medical devices and strengthen its…
